Real-world Evidence (RWE) has an increasingly important role to play in allowing everyone to have access to effective and safe OTC medicines. Hurdles remain in generating as well as applying RWE and patient experiences to non-prescription medicines.

How will these hurdles be overcome as we drive the next generation of OTC medicines in self-care?

This webinar features a fantastic panel of expert industry voices, including:

• Christelle Anquez-Traxler, Regulatory and Scientific Affairs Manager, AESGP
• Emese Csőke, Global Regulatory Medical Safety and Compliance (RMSC) Strategy Director and Chief of Staff, Bayer Consumer Health
• Dr. Sabine Landes, Medical Head CHC Germany, Sanofi Consumer Healthcare
• Denise Pohlhaus, Director Digital Solutions, GSK Consumer Healthcare
• Dr. Volker Spitzer, Global Senior Director, R&D Services, IQVIA Consumer Health

Watch back this insightful webinar now, see timecodes below:

• 01:49 – Dr Volker Spitzer discusses the current state of play and why RWE now forms and important part of the OTC Medicines development process.
• 07:53 – Emese Csőke gives an overview of a recent article driven by the association of the European self-care industry, the AESGP – the voice of the consumer health industry in Europe - and published in Clinical and Translational Science Journal – titled How can real-world evidence aid decision making during the lifecycle of non-prescription medicines.
• 14:04 - Emese Csőke discusses the difference between Pharma and OTC, and the data gaps that exist for RWE.
• 18:11 - Christelle Anquez-Traxler answers “How can we foster routinely collected data for OTC as well as encourage the consideration of observational data around non-prescription medicines?”.
• 20:24 - Denise Pohlhaus delves into the opportunities that patient generated health data presents for OTC RWE.
• 25:04 - Christelle Anquez-Traxler discusses where RWE can aid decision making in Rx-to-OTC Switch.
• 28:00 – Denise Pohlhaus moves onto how RWE aids decision making in post marketing safety.
• 37:07 – Dr. Sabine Landes then follows this with how RWE aids decision making in relation to real-life effectiveness.
• 36:28 – Our panel discusses the biggest hurdles for utilizing RWE in the OTC space.
• 37:51 – Our panel gives their opinion on the one thing that needs to happen next to ensure the power of RWE can be harnessed to help drive the future of OTC medicines.
• 41:19 – Live Q&A.
• 55:23 – Dr Volker Spitzer concludes the webinar and shares his final thoughts on what is needed to make RWE and digital research successful.

You can download the presentation here, and visit our Product and Claim Development page to learn more about our solutions.

If you have an RFP in the area discussed during this webinar, please click the Green “CONTACT US” button floating on the bottom right of this page to discover the right solutions for you.